With new opportunities emerging and new, stricter rules and regulations raising the bar even higher, the pharmaceutical landscape is changing radically. Joining these developments is China’s rapidly expanding and diversifying pharmaceutical market, which is set to enter the world’s top ten in the next five years.

              

In the midst of all the turmoil, CPhI, ICSE and P-MEC China continue to give the pharmaceutical world a clear and unrivalled insight in new developments and opportunities in the Chinese and international markets.

 

CPhI China 2009 will be hold in 23-25 June 2009 at Shanghai New International Expo Centre (SNIEC), and we DAWNRAYS’s booth No. is E2G22.

 

Dawnrays is engaged in the development, manufacturing and marketing of APIs (such as Ceftriaxone Sodium Sterile, Cefotaxime Sodium Sterile, Cefoperazone Sodium and sulbactam sodium sterile 1:1, Cefoperazone Sodium and sulbactam sodium sterile 2:1, Cefoperazone Sodium Sterile, Sulbactam Sodium Sterile, cefepime hydrochloride sterile (with arginine), Tazobactam Sodium Sterile, ceftazidime sterile (with sodium carbonate)), Intermediates(such as Ceftriaxone Sodium Crude, Cefoperazone Acid, Sulbactam Acid, Cefotaxime Acid, Ceftazidime 2HCL, Cefepime Hydrochloride non-sterile, Cefoxitin Acid, 7-TMCA, 7-MPCA, 7-ACT ), and Formulations (such as Ceftriaxone Sodium for Injection, Cefotaxime Sodium for Injection, Ceftazidime for Injection, Cefoperazone Sodium and Sulbactam Sodium for Injection(1:1), Cefoperazone Sodium and Sulbactam Sodium for Injection(2:1), Cefoperazone Sodium for Injection, Cefuroxime Sodium for Injection, Cefepime Dyhydrochloride for Injection, Cefonicid Sodium for Injection, Cefminox Sodium for Injection, Cefpirome Sulfate for Injection) of Cephalosporin. Dawnrays is also in position to supply Specialty Drugs, such as Amlodipine Besylate Tablets.

 

Welcome to attend CPHI CHINA 2009 and visit our booth!